Lakewood-Amedex Biotherapeutics Inc. (LABT)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$0.0M
Cash & Equivalents
$0.4M
Quarterly Burn Rate
$5M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

DateEventDrug
2026-12-01 Phase2 Readout —

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for LABT.

SEC EDGAR Filings

All SEC filings for Lakewood-Amedex Biotherapeutics Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.